Parkinsonism & Related Disorders

Article	Citations
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease	114
Error-based biofeedback for gait training in Parkinson's disease	78
Dual Phase 18F-FP-CIT PET in presynaptic and trans-synaptic nigrostriatal dysfunction in Multiple System Atrophy	75
APOE carrier status and cognitive outcomes after STN-DBS surgery for Parkinson’s disease.	66
Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin	65
A case of probable Progressive Supranuclear Palsy Frontal type (PSP-F) presenting as psychosis	62
Leveraging Telehealth and Wearables for Parkinson’s Disease: Innovative Approaches to Enhance Personalized Care	60
Effect of ND0612 Continuous Infusion on Motor Performance and Experiences of Daily Living in Patients With Parkinson’s Disease	57
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 2021	55
Neurocognition, Cerebellar Functions and Psychiatric Features in Spinocerebellar Ataxia Type 34	54
Effects of an intensive, multidisciplinary rehabilitative treatment in an outpatient setting on clinical outcomes in Parkinson’s Disease: preliminary results.	51
FindPD.DaT: Development of a Novel Artificial Intelligence-driven Tool for Diagnosis of Parkinson’s Disease using Dopamine Transporter Scans	51
Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson’s Disease using accelerometry	45
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome	37
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease	36
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder	36
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease	35
Chorea-Acanthocytosis: A Case Report	34
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment	33
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention	33
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.	32
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease	31
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease	31
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation	30
Evaluation of mild cognitive impairment in older patients with essential tremor	30

Psychometric analysis of the short form UCLA Loneliness Scale (ULS-8) in people with Parkinson's disease	28
Asymmetric Parkinsonism and Ataxia with autonomic dysfunction and RBD	28
The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials	28
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease	27
Prevalence and clinical impact of alpha-synuclein pathology in idiopathic normal pressure hydrocephalus: Insights from RT-QuIC assay	27
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease	27
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school	27
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit	27
Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?	26
Magnetic resonance spectroscopy reveals evidence of brain oxidative stress in Tourette syndrome	26
A useful cognitive motor dual task paradigm in prodromal and manifest Huntington’s disease	25
Foslevodopa/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to levodopa-carbidopa intestinal gel delivered to the jejunum	25
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyse	25
Retinal microvascular impairment in Parkinson's disease with cognitive dysfunction	25
Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration	25
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex	24
Symptom onset lateralization and bilaterality in Parkinson's disease: Clinical implications of motor and non-motor profiles	23
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents	23
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study	23
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?	22
Diagnosis of vascular parkinsonism: A new tool for gait hypokinesia occurring in older persons	22
Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease	22
Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder	21
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors	21
Postural abnormalities in Asian and Caucasian Parkinson's disease patients: A multicenter study	21
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia	21
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease	21
White matter connectivity networks predict early dementia conversion in Parkinson’s disease	21
Bilateral Hemimasticatory spasm in a patient with hypereosinophilic syndrome	21
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia	21
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS	21
The Elevated Risk of Dementia in Parkinson's Disease Patients Associated with Metabolic Syndrome	20
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?	20
Huntington Disease – Update on Recent Advances and a Look Toward the Future	20
Study of 17β estradiol with neuropeptide and amyloid beta fragment on neuronal and biochemical functions in naturally menopausal aging rats	20
Perry disease in an Argentine family due to the DCTN1 p.G67D variant	20
Machine Learning Analysis of the Interaction Between miR-155 and LRRK2 Gene Variants in Parkinson's Disease Progression	20
Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study	20
Unveiling the Complexity of Parkinson's Disease: Exploring Subtypes and Tracing its Five-Stage Natural Course	19
Establishing exercise habits in patients with Parkinson's disease through an exercise group model	19
The characteristic and prognostic role of blood inflammatory markers in patients with Huntington's disease from China	19
Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype?	19
Somnolence-Related Events Over Time During Valbenazine Treatment for Chorea Associated with Huntington’s Disease	19
The role of neurotrophic factors in development Parkinson's disease dementia	19
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism	19
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	19
Clinical Evaluation of Parkinson's Disease Patients Admitted to the Movement Disorders Outpatient Clinic of Istanbul Taksim Training and Research Hospital, Turkey, 2023	19
Efficacy of Once-Daily Valbenazine in Adults with Chorea Associated with Huntington’s Disease: Effect Size Over Time	19
Commentary on “The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials”	18
Tardive dyskinesia versus tardive syndrome. What is in a name?	18

Association of bilateral oophorectomy with incidence of Parkinson's disease: A systematic review and meta-analysis	18
Editorial Board	18
Hereditary Spastic Paraparesis with SPG6 mutation: First case report from Malaysia	18
Gerstmann-Straussler-Scheinker disease: Lessons from two new Indian kindreds	18
Differences in progressive supranuclear palsy in patients of Asian ancestry?	18
From writer's cramp to blepharoclonus: An atypical journey with a novel KMT2B variant	17
Atypical Presentation of Autosomal Recessive Cerebellar Ataxia Type I Mimicking Amyotrophic Lateral Sclerosis	17
A young man with progressive dysarthria, generalized slowness and memory loss	17
Dentate calcifications with palatal tremor and facial myorhythmia in adult-onset Cerebral X-linked Adrenoleukodystrophy	17
Functional movement disorders in dopa-responsive dystonia	17
Impact of inpatient mobility on outcomes in Parkinson's disease	17
The BEACON Study: LRRK2 inhibition by BIIB122/DNL151 in participants with Pathogenic LRRK2 Variants and Parkinson’s disease	16
Effect of Safinamide on Non-motor symptoms and QoL According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose	16
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease	16
Personality assessment with Temperament and Character Inventory in Parkinson's disease	16
Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease	16
Dopaminergic dysfunctions instigated by Nano-formulation of Neonicotinoid pesticides in mice	16
Expanding the phenotypic and genotypic spectrum of DYT-TUBB4A with seven patients from India	16
Protective Lifestyle Risk Factors Against Parkinson’s Disease In Sub-Saharan Africa: A Review On Current Evidence	16
On demand inhaled levodopa in Parkinson´s disease (pd) patients with device assisted therapies	16
Augmented reality cueing for freezing of gait: Reviewing an emerging therapy	16
Distractibility predicts favourable response of functional tremor to transcranial magnetic stimulation: An electrophysiological study	16
Colony-Stimulating Factor-1 Receptor-Related Disorders in the Hispanic Population: A Report of six Families	16
Segmental dystonia as the prominent phenotype resulting from a MICU1 splice variant in a new Indian case	15
Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy	15
Editorial Board	15
Editorial Board	15
The distinctive functional connectivity of the cholinergic nucleus basalis of Meynert in Parkinson’s disease across different cognitive status	15
The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease	15
A late-onset neurological disorder: Is progression inevitable? Expert Commentary	15
Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy	15
Sex differences for cognitive decline in progressive supranuclear palsy	15
Proteomic profile of saliva in patients with Parkinson's disease after the practice of interval exercise	15
¿It Is Any Difference Between Directional Vs Omnidirectional Lead For Treatment In Parkinson Disease?	15
Levodopa, homocysteine and Parkinson's disease: What's the problem?	15
Single-dose intranasal administration of α-syn PFFs induce lewy neurite-like pathology in olfactory bulbs	15
Editorial Board	15
Genetic study of early-onset Parkinson's disease in the Malaysian population	15
A de novo GRIA3 variant with complex hyperkinetic movement disorder in a girl with developmental delay and self-limited epilepsy	15
Efficacy and safety of high doses of safinamide in advanced Parkinson disease	15
Brittle dyskinesias after bilateral STN DBS: dissociation of microlesioning effect on tremor versus on dyskinesias	15
Atypical antipsychotic use and mortality risk in Parkinson disease	14
Genetic overlap between dystonia and other neurologic disorders: A study of 1,100 exomes	14
MRI index of glymphatic system mediates the influence of locus coeruleus on cognition in Parkinson's disease	14
Phenotypic manifestations of KIF5A Arg1007Lys mutation: A large kindred study	14
Motor and non-motor responses of STN DBS in early onset PLA2G6 related Parkinsonism with compound heterozygous mutation from China	14
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis	14
Frequency settings of subthalamic nucleus DBS for Parkinson's disease: A systematic review and network meta-analysis	14
Machine Learning-based World Health Organization Disability Assessment Schedule for persons with Parkinson's disease	14
The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study	14
Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective	14
Cognitive and neuropathological contributions to gait dysfunction in Parkinson's disease	14
Diagnostic performance of T1-Weighted MRI gray matter biomarkers in Parkinson's disease: A systematic review and meta-analysis	14
Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial	14
Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks	14
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	13
REM density in Parkinson’s disease: Effects of motor, cognitive, and autonomic function, and the impact of evening dopaminergic medication	13
Identification of the needs of patients with Parkinson’s disease through a qualitative research process	13
The role of semispinalis capitis muscles in cervical dystonia with goose-neck posture	13
Sexual dysfunction in patients with focal dystonia	13
Recent advances in non-Huntington's disease choreas	13
Cerebellar blood perfusion is a diagnostic, but not a prognostic, marker for parkinsonian-dominant type multiple system atrophy	13
Correcting vertical perception to reverse Pisa syndrome in Parkinson's disease: A case report	13
Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) Presenting With Parkinsonism Findings: A Case Report	13
Introducing Virtual Shared Medical Appointments as a Novel Treatment Platform for Functional Movement Disorders	13
Neuropsychological studies in children with tic hyperkinesis	13
Cropland associated with risk of Parkinson's disease in the northern Great Plains	13
Patients with progressive supranuclear palsy need to be seen sooner and more frequently	13
Interaction between caffeine intake and polymorphisms of PARK16 modifies Parkinson’s Disease risk	13
Convergence insufficiency and Parkinson's disease progression	13
The factors for choosing intesticular gel therapy	13
ERCC4 variants causing neurodegeneration with ataxia and chorea in three siblings in Lithuanian family	13
Improvement of non-motor symptoms with NE3107 adjunctive to Carbidopa / Levodopa in patients with Parkinson`s disease: A Phase 2A, placebo-controlled study	13
The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials	13
Tongue strength in progressive supranuclear palsy	13
Thyroid disease in cervical dystonia	12
Tremor is associated with familial clustering of dystonia	12
The feasibility of using loss of “swallow tail sign” on 3T – susceptibility weighted MRI in diagnosis of Parkinson’s disease	12
A case of treatable encephalopathy, developmental regression, and proximal tremor: Expert commentary	12
Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson's disease	12

Dopaminergic connectivity reconfiguration in the dementia with Lewy bodies continuum	12
Motor band sign in a Huntington disease phenocopy	12
Grey matter correlates of dystonic soft signs in essential tremor	12
Seronegative basal ganglia encephalitis mimicking dementia of Lewy body	12
Transcranial high-intensity Magnetic Resonance-guided focused ultrasound (tcMRgFUS) – safety and impacts on tremor severity and quality of life	12
Comment on “Defining ‘OFF’ time in device-aided therapy criteria for Parkinson's disease: Gaps and opportunities”	12
Spinocerebellar ataxia subtype 40: Report of a case and review of literature	12
Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson's disease	12
Expanding the genotype-phenotype landscape of PDE10A-associated movement disorders	12
“A man with an arched back”: Expert commentary	12
Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline	12
Sweet as Parkinson's disease: Rethinking the impact of diabetes mellitus	12
Analysis of GIPC1 CGG repeat expansions in essential tremor	12
Longitudinal evaluation of patients with isolated head tremor	12
A structural perspective on the interaction between glucocerebrosidase and the positive allosteric modulator BIA 28-6156	11
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study	11
Fecal tyrosine decarboxylase and motor response complications in Parkinson's disease	11
Development of a screening AI model for Parkinson's disease using gait image sequences	11
Late-onset parkinsonism in a patient with a novel frameshift THAP1 variant	11
Calcium channel blockers and Parkinson's disease: A systematic review and meta-analysis	11
Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions	11
Cognitive function, psychobehavioral symptoms, and MRI features in patients with non-demented Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies	11
Empowering the management of early-onset Parkinson’s disease: The role of technology	11
WITHDRAWN	11
Right to the Point - A Writer’s Cramp Successful Treatment	11
Sex differences in the association between nonalcoholic fatty liver disease and Parkinson's disease	11
Accelerometric quantification of MDS-UPDRS bradykinesia measurements in PD patients: A pilot study	11
Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis	11
MRgFUS of the nucleus ventralis intermedius in essential tremor modulates functional connectivity within the classical tremor network and beyond	11
The effects of once-daily opicapone 50 mg on the pharmacokinetics of levodopa administered as carbidopa/levodopa extended-release capsules: an open-label study	11
TorsinA-interacting protein 2 (TOR1AIP2) variants in an autosomal dominant combined dystonia-hemichorea-hemiballismus syndrome in two families	11
Opicapone Effect on Sleep Disorders in Fluctuating Parkinson’s Disease Patients: Findings from the OASIS Trial	11
Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)	11
Usage of modern technologies like VR therapy, physio therapy along with levodopa in Young-Onset Parkinson's disease patients	11
Response to levodopa in Parkinson's disease over time. A 4-year follow-up study	11
Post-COVID parkinsonism: A scoping review	11
Real-world effect of age on long-term effectiveness and safety of levodopa-carbidopa intestinal gel: post hoc analysis from the DUOGLOBE study	11
Ethnoracial differences for caregiving burden in Parkinson’s disease	11
Reliability of remote video ratings of the scale for assessment and rating of ataxia	11
Magnetic Resonance Imaging Marker for the Conversion from Idiopathic Late-onset Cerebellar Ataxia to Multiple System Atrophy	11
A Novel Missense Mutation in the Spectrin Repeat of SPTBN2 Identified in Spinocerebellar Ataxia Type 5	10
Resting-state EEG predicts cognitive decline in a neuropathologically diagnosed longitudinal community autopsied cohort	10
TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome	10
Utility of clinical tests for asymmetry in Parkinson's disease and Atypical Parkinsonian disorders: the PARK-SYMM scale study.	10
Parkinson's disease patients with absence of normal dipping status were more vulnerable to cognitive impairment from the early stages	10
Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease	10
The use of botulinum toxin A in the treatment of hand tremor	10
A challenging case of cerebellar ataxia associated with oro facial dominant chorea	10
An atypical case of head tremor	10
A benign course of Parkinson's disease associated with different mutations in the glucocerebrosidase gene – A case series	10
Symptom changes with hormonal variations in genetic dystonia	10
Exploring Novel Therapeutic Approaches in Parkinson’s Disease: A Comprehensive Review	10
Assessment of Cerebral Cortical Atrophy Using Visual Rating Scale in Patients with Functional Movement Disorder	10
Developing a Female-Specific Mouse Model for Parkinson’s Disease Using a High-Sensitivity Neural Network	10
The influence of fatigue on motor imagery ability in people with Parkinson’s disease – preliminary study	10
Non-pharmacological rehabilitation for people living with advanced Parkinson's disease: A scoping review of interventions	10
Challenges during prayer (namaz/salah) rituals in Muslim patients with Parkinson’s disease	10
Exposure factors and clinical characteristics associated with Parkinson's disease in GBA1 variant carriers: A Chinese GBA1-PD intrafamilial survey	10
Real-world local field potential recordings in patients with deep brain stimulation for Parkinson's disease	10
Demonstration of a Prototype Clinical Decision Support System for Diagnosing Parkinson’s Disease	10
Influence of Toxic Exposure on the Age of Onset of Parkinson's Disease: An Observational and Analytical Study.	10
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables	10
Enhanced low beta activity in Park2-associated Parkinson’s disease	10
Analysis of interleukin-6 levels in patients with Parkinson's disease by disease stage	10
Profile of patients with advanced Parkinson’s disease treated with Levodopa–entacapone–carbidopa intestinal gel (LECIG)	10
Real world evidence of efficacy ad safety of subcutaneus foslevodopa/foscarbidopa infusion in advanced Parkinson disease	9
MOBP gene risk variant is associated with higher cerebrospinal fluid levels of neurofilament light chain: a Barcelona PSP Registry study	9
Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy	9
A case of treatable encephalopathy, developmental regression, and proximal tremor	9
Inter-muscular coherence in speed skaters with skater's cramp	9
Editorial Board	9
Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study	9
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation	9
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel	9
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease	9
Efficacy of Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis	9
A multidisciplinary telemedicine approach for managing frailty in Parkinson's disease. A longitudinal, case-control study	9
A relatively common hypomorphic variant in WARS2 causes monogenic disease	9
Backward leaning during gait: An underrecognized sign in Niemann-Pick type C	9
High preoperative gait variability is a prognostic predictor of gait and balance in Parkinson disease patients with deep brain stimulation	9
Decreased cerebral ATP in pre-motor manifest Huntington's disease: A pilot study	9
Magnetic Resonance–Guided focused ultrasound surgery for Parkinson's disease: A mini-review and comparison between deep brain stimulation	9
tDCS application for postural control in Parkinson's disease: Effects are associated with baseline characteristics	9
Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders	9
Clinical progression of vascular Parkinsonism in ischemic stroke patients with metabolic syndrome	9
Other clinical uses for apomorphine: Sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury, sexual dysfunction	9
Long-term safety of continuous levodopa/carbidopa infusion with ND0612: results from the ongoing BeyoND study	9
Diagnosis across a cohort of “atypical” atypical and complex parkinsonism	9
Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy	9
Cerebral microbleeds in dementia with Lewy bodies	9
Editorial Board	9
Functional movement disorder comorbidity in Parkinson's disease: A multicenter descriptive study	9
Are we ready for automated deep brain stimulation programming?	8
Changes of vagus nerve cross-sectional area as a disease-specific imaging biomarker in early Parkinson’s disease patients	8
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies	8